BACKGROUND: Transfusion can cause severe acute lung injury, although most transfusions do not seem to induce complications. We tested the hypothesis that transfusion can cause mild pulmonary dysfunction that has not been noticed clinically and is not sufficiently severe to fit the definition of transfusion-related acute lung injury. METHODS: We studied 35 healthy, normal volunteers who donated 1 U of blood 4 weeks and another 3 weeks before 2 study days separated by 1 week. On study days, 2 U of blood were withdrawn while maintaining isovolemia, followed by transfusion with either the volunteer's autologous fresh red blood cells (RBCs) removed 2 hours earlier or their autologous stored RBCs (random order). The following week, each volunteer was studied again, transfused with the RBCs of the other storage duration. The primary outcome variable was the change in alveolar to arterial difference in oxygen partial pressure (AaDO 2 ) from before to 60 minutes after transfusion with fresh or older RBCs. RESULTS: Fresh RBCs and RBCs stored for 24.5 days equally (P ϭ 0.85) caused an increase of AaDO 2 (fresh: 2.8 mm Hg [95% confidence interval: 0.8 -4.8; P ϭ 0.007]; stored: 3.0 mm Hg [1.4 -4.7; P ϭ 0.0006]). Concentrations of all measured cytokines, except for interleukin-10 (P ϭ 0.15), were less in stored leukoreduced (LR) than stored non-LR packed RBCs; however, vascular endothelial growth factor was the only measured in vivo cytokine that increased more after transfusion with LR than non-LR stored packed RBCs. Vascular endothelial growth factor was the only cytokine tested with in vivo concentrations that correlated with AaDO 2 . CONCLUSION: RBC transfusion causes subtle pulmonary dysfunction, as evidenced by impaired gas exchange for oxygen, supporting our hypothesis that lung impairment after transfusion includes a wide spectrum of physiologic derangements and may not require an existing state of altered physiology. These data do not support the hypothesis that transfusion of RBCs stored for Ͼ21 days is more injurious than that of fresh RBCs. (Anesth Analg 2012;114:511-9) 
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In a retrospective chart review of critically ill patients, without case cohort controls, Cornet at al. 7 noted a decreased Pao 2 /fraction of inspired oxygen (Fio 2 ) 24 hours after leukoreduced (LR) red blood cell (RBC) transfusion. Covin et al. 8 reported a single case of acute transient pulmonary insufficiency after transfusion during surgery of an autologous unit of RBCs that when tested had significant lipid-priming activity. Whereas antibody mediation is an accepted etiology of TRALI, the latter case report and several laboratory experiments 9 -12 support the additional thesis that pulmonary injury after transfusion may also be caused by infusion of active biologic substances (cytokines, phospholipids) that activate neutrophils that have been primed by an existing abnormal physiologic state. However, there are no data from prospective randomized studies in humans that sought subtle changes in pulmonary function after transfusion, while at the same time comparing any such effects after transfusion of "fresh" RBCs with those that have been stored for substantial periods of time sufficient to accumulate the implicated biologically active compounds. Some retrospective analyses of databases have noted an association of transfusion of RBCs stored for a longer time with an increased incidence of adverse clinical outcomes than with transfusion of RBCs stored for lesser periods of time. 13 However, other similar analyses, 14 -16 including a recent larger, more carefully analyzed database of all transfused people in Denmark and Sweden, did not confirm those findings. 17 Accordingly, we tested the following hypotheses: (1) that transfusion results in subclinical alterations of pulmonary function in normal humans who do not have an existing condition that causes neutrophil priming; (2) that transfused cytokines in blood components are associated with altered pulmonary function in normal humans; and (3) that transfused RBCs stored for a relatively long time compared with those stored for a lesser period produce subtle changes in pulmonary function.
METHODS
To test the hypothesis that transfusion can produce relatively small, detectable changes of pulmonary function, and not only severe damage (with a low incidence), we assessed oxygenation and pulmonary dead space fraction. We assessed the latter because increased dead space fraction is an early feature of acute lung injury. 18 These variables were assessed in healthy volunteers transfused with autologous stored (LR or not LR) or autologous fresh RBCs, so that results would not be affected by the presence of disease or concurrent medications.
Thirty-five healthy volunteers were studied with their signed written informed consent and with the approval of the IRB of the University of California, San Francisco (UCSF). Criteria for enrollment were that volunteers were required to be healthy as determined by history and physical examination, be nonsmokers, of age 18 to 35 years, have a body weight Ն110 lbs., a hematocrit Ն0.34, and be taking no medications other than for birth control.
After each volunteer gave their informed consent they were randomly allocated to 1 of 4 groups based on whether or not their donated blood was to be LR, and whether they would have the first study day as return of fresh or stored blood (see below). Randomization was accomplished using computerized code written for SAS version 9.1 (SAS Institute, Inc., Cary, NC) using blocks of 4 volunteers. The study coordinator accessed the randomization code for 1 volunteer at a time. The volunteers and the investigators involved in data collection and analysis of study end points were blinded to group allocation. The study coordinator and 1 physician not involved in data collection that day were not blinded for that day so that they could perform the required checks of the recipient and the units of RBCs to be transfused.
One unit of blood (450 mL) was withdrawn from each volunteer approximately 4 weeks before the study days, and a second unit approximately 3 weeks before. Blood was collected into Fenwal/Baxter bags with CPDA-1 (Fenwal Division, Baxter Healthcare Corp., Deerfield, IL) with or without (randomly allocated) an inline whole blood leukoreduction filter (Sepacell RS-2000; Asahi Kasei Kuraray Medical Co., Ltd.; Asahi Kasei Corp., Tokyo, Japan). The whole blood was separated by standard procedures in the UCSF blood bank and stored as packed RBCs (PRBCs) in the UCSF blood bank under standard conditions. Each volunteer was studied twice, on 2 different days, separated by 1 week (Fig. 1) . On each of the 2 study days, the volunteer rested in a semirecumbent position, with his or her head elevated at approximately 30°to 45°. The same elevation was maintained, as the angle of the lungs influences respiratory quotient (R) and dead space to tidal volume ratio (Vd/Vt). 19 An IV cannula (16 or 18 gauge) was placed in each arm, and a 22-gauge cannula inserted in a radial artery after infiltration with a local anesthetic. After 10 to 15 minutes of quiet rest, the volunteer was fitted with a nose clip so that all breathing was through the mouth. On the first study day, the subject had a practice session for familiarization with the equipment and procedures. During test periods (15 Red Cell Transfusion Induces Gas Exchange Deficit in Humans breathed room air through a rubber mouthpiece that was connected to a low-resistance valve (model 2630; Hans Rudolph, Inc., Kansas City, MO), into a Douglas bag. A low-resistance 3-way valve was interposed between the large-bore (43-mm diameter) tubing connecting the Rudolph valve and the Douglas bag, allowing the subject to exhale through the system without collection of expired gas until stability had been reached for at least several minutes. Stability was determined by constant monitoring of mixed expired partial pressure of CO 2 (CO 2 sensor P-61B and CO 2 analyzer CD-3A; AEI Technologies, Pittsburgh, PA). These instruments were calibrated at the start of each study day, and several times during each study day. Electrical signals were recorded using a Macintosh computer with software written by one of us (JF) for LabVIEW (version 8.5 or 8.6; National Instruments Corporation, Austin, TX). After mixed expired CO 2 stabilized, expired gas was collected for 3 minutes in a Douglas bag that had been previously completely evacuated by use of suction.
During each test period, in addition to determination of mixed expired partial pressures of O 2 and CO 2 , blood was sampled from the arterial cannula for measurement of blood gases (ABL 500 or ABL 800; Radiometer America, Cleveland, OH), complete blood count, cytokine concentrations (see below), hemoglobin concentration, and oxyhemoglobin saturation (OSM 3 Hemoximeter; Radiometer America).
After initial measurements, 2 U (450 mL each) of blood were withdrawn through an IV cannula into a standard blood collection bag containing CPDA-1 (Fenwal/Baxter). These units were not LR on either study day and were processed into PRBCs by the UCSF blood bank in standard fashion. Albumin, human 5% (Grifols, Los Angeles, CA) was simultaneously infused through the IV cannula in the other arm, to maintain isovolemia (1.1 times the volume of blood removed 20 ) . A second set of measurements was made (see above; Fig. 1 ) and a sample of blood was taken 15 minutes (95% CI: 14 -16 minutes) after completion of this procedure.
After a rest period of 60 minutes (95% CI: 57-63 minutes), 2 U of autologous RBCs (approximate volume 193 mL per unit) were infused for 28 minutes (95% CI: 26 -30 minutes). On one study day, the infused erythrocytes were those stored for 3 to 4 weeks, and on the other study day, they were the erythrocytes withdrawn the day of the study (order of study days randomly allocated). Each volunteer was studied with both fresh and stored RBCs, on separate days. Stored erythrocytes were randomly allocated to be LR or not. On both study days, another set of measurements and collection of blood samples was performed 66 minutes (95% CI: 65-67 minutes) later.
Cytokines
We measured the following cytokine concentrations 
Primary End Point
The pulmonary gradient for oxygen-the difference between partial pressures of oxygen in the alveoli (Pao 2 ) and arterial blood (Pao 2 )-(AaDo 2 ) was assessed on each study day after isovolemic removal of 2 U of blood (before transfusion of PRBCs), and again after transfusion of the autologous PRBCs. The primary end point of the study was the difference of the effect of stored autologous RBCs with that of fresh autologous RBCs on the change of AaDo 2 between these 2 times.
The Pao 2 was calculated from the alveolar gas equation 21 :
R was assumed to be 0.86.
22,23

Secondary End Point
The secondary end point was the difference in change of Vd/Vt from after withdrawal of 2 U of blood but before transfusion to after transfusion, between stored autologous and fresh autologous RBCs. Vd/Vt was calculated as: (Paco 2 Ϫ Peco 2 )/Paco 2 where Peco 2 is the partial pressure of CO 2 in mixed expired gas.
Statistics
We determined the number of volunteers to be studied by an a priori 2-tailed power analysis using preliminary data from healthy patients transfused during posterior spinal surgery. The analysis, assuming a correlation of 0.5 between changes in one condition compared with changes in the second condition, determined that studying 35 volunteers would give the study a power of 0.8 with an ␣ of 0.05. We had planned to study 38 volunteers to allow for 3 volunteers to withdraw before completing the full study; however, that was not necessary because all completed the study.
Data were tested for normal distribution using the Shapiro-Wilk test. Comparisons between groups and within groups (measurements made after removal of blood but before transfusion were compared with those made 66 minutes after transfusion) were performed using the Student paired t test. For data that were not normally distributed (cytokines), comparisons were made using the Mann-Whitney U and Wilcoxon signed rank tests. A nonparametric test, Spearman , was used to test for correlation among cytokine concentrations. Examination of possible effects of order of experimental day (fresh or stored), AaDo 2 , Pao 2 , and Vd/Vt were compared for all volunteers using the Student paired t test. All tests were 2 sided. Statistical tests were performed using JMP (version 7.0; SAS Institute) or InStat (version 3.0b for Macintosh; GraphPad Software, Inc., La Jolla, CA). Statistical significance was accepted at P Յ 0.05. Presented P values were not modified for analyses of multiple testing of cytokine concentrations and associations.
Data are presented as mean (95% CI) or median (interquartile range) unless otherwise indicated.
RESULTS
Thirty-five volunteers completed the study; 20 transfused with LR RBCs, and 15 transfused with non-LR RBCs. There were no statistical differences for gender, age, ethnicity, height, weight, or body mass index between those transfused with LR or non-LR RBCs (Table 1) .
"Fresh" RBCs were transfused 1.67 hours (95% CI: 1.53-1.80 hours), and "stored" RBCs were transfused 24.5 days (24.0 -24.9 days) after collection.
Pulmonary
Data from 3 volunteers were excluded from analysis (1 LR, 2 not LR) for AaDo 2 , Pao 2 , and Vd/Vt because of calibration errors of the blood gas instrument. (Fig. 2) . The difference in AaDo 2 from before to after RBC transfusion between fresh and older RBCs was 0.24 mm Hg (95% CI: Ϫ2.8 to 3.2 mm Hg). This value is 8% of the effect size, a value substantially less than that frequently required to establish "equivalence."
Primary Outcome
AaDo 2 was greater (P ϭ 0.021) after transfusion of stored Data are mean Ϯ SD, or number (%). "Leukoreduced" indicates whether autologous packed red blood cells were leukoreduced for "stored" day. BMI ϭ body mass index. P value is the probability of difference between volunteers that had leukoreduced packed red blood cells and those who did not. (Fig. 4) . There was no statistical difference between these tiny changes comparing transfusion of fresh RBCs with that of stored RBCs (P ϭ 0.76).
Ratio of Respiratory Dead Space Volume to Tidal Volume
The order of experimental day (fresh or stored) did not affect changes caused by transfusion for AaDo 2 (P Ͼ 0.99), Pao 2 (P ϭ 0.67), or Vd/Vt (P ϭ 0.77).
Cytokines
All cytokine concentrations were analyzed statistically using the Wilcoxon signed rank test, because nearly all were not distributed normally.
Transfused RBCs (In Vitro)
Concentrations of all measured cytokines were less in LR RBCs than fresh RBCs (all P Ͻ 0.0001). All cytokines in stored LR RBCs were less than in stored non-LR RBCs (all P Ͻ 0.0001 except granulocyte macrophage-colony stimulating factor, P ϭ 0.008), except for IL-10 (P ϭ 0.15).
In Vivo
Nearly all in vivo cytokine concentrations after blood withdrawal ("dilution") did not differ between fresh and stored days or between those who were to receive LR or non-LR RBCs. Transfusion of LR RBCs on the fresh day did not change in vivo concentration of any cytokine in the LR group. In the non-LR group on the fresh day, transfusion of non-LR RBCs did produce a few statistically significant, but relatively modest changes in some cytokine concentrations. 
DISCUSSION
The main findings of this study are: (1) autologous RBC transfusion produces a mild decrement in gas exchange in normal healthy adults; (2) the pulmonary effects do not differ between RBCs that are fresh or have been stored for Ͼ21 days; (3) the pulmonary impairment is not affected by leukoreduction of the transfused RBCs despite a larger concentration of cytokines in the non-LR stored PRBCs than in the LR stored PRBCs; (4) transfusion of autologous RBCs increased the in vivo concentrations of several cytokines; and (5) VEGF was the only cytokine tested with in vivo concentrations that correlated with AaDo 2 .
The data reported herein demonstrate that RBC transfusion results in a subtle decrement of pulmonary gas exchange for oxygen, supporting our hypothesis that lung injury related to RBC transfusion may produce a wider spectrum in humans than has been hitherto recognized, and not only overt TRALI. RBC transfusion may cause lung injury in animal models, but the limited data in humans supporting this concept emanate primarily from severe injury (TRALI) and retrospective analyses of databases. There have been 2 mechanisms postulated for such injury: (1) damage mediated by antibodies in donor plasma; and (2) damage induced by biologically active compounds in stored blood or blood components. Our experimental design allowed us to test the second possibility by transfusing autologous RBCs, thus eliminating the possibility of an antibody-mediated process. We demonstrated that transfusion of autologous RBCs causes a change in pulmonary gas exchange of oxygen, albeit small and in healthy volunteers, as well as an increase of concentrations of several in vivo cytokines after transfusion, thus implicating biologically active compounds as a likely etiology. Additional evidence points to the potential of neutrophil-platelet aggregates in producing organ damage. 24, 25 It is possible that the effects we observed might be accentuated by a patient's clinical condition before transfusion. Such patient risk factors for the development of TRALI have been identified recently in a large, prospective, observational study. 26 Stored RBCs have a relatively small amount of plasma stored and administered with them. Accordingly, the number of cases and incidence of severe lung injury and death attributed to RBC transfusion has been relatively low compared with those attributed to transfusion of plasma or platelets. 5 Thus, the second etiology would seem more likely for many cases in which RBC transfusion may be implicated as causing lung injury. Data from laboratory experiments are not unanimous as to whether RBCs alone without a "first hit" and primed neutrophils can cause lung injury. 10, [27] [28] [29] [30] Our data demonstrate that RBC transfusion in healthy humans, without a first hit, and without a possible antibody-antigen mechanism can alter pulmonary function. Thus, the etiology of the changes observed in our volunteers must have been mediated by a mechanism not involving antibodies.
A potential mechanism for RBC-induced pulmonary injury is that of alteration of the pulmonary microvascular endothelium. Supernatant fluid from human RBCs stored for 3 days to 6 weeks increases the permeability of human lung microvascular endothelial cell monolayers. 31 VEGF has a similar action, 32 and increases pulmonary vascular permeability 33 increasing pulmonary edema in mice. 34, 35 In our experiments, VEGF was the only cytokine in vivo concentrations that correlated with AaDo 2 . VEGF-induced increased permeability of pulmonary endothelial cells could explain our finding of increased AaDo 2 with transfusion and may be a contributing factor to TRALI and transfusion-associated circulatory overload as well. However, our finding of an association of in vivo concentrations of VEGF with AaDo 2 is not a determination of a cause-andeffect relationship.
It has been more difficult to implicate RBC transfusion as a cause of human clinical pulmonary dysfunction. Retrospective database analyses have been inconsistent in attempts to find associations between RBC transfusion and morbidities, including pulmonary dysfunction or infection, 7,13,14,36 -41 prompting the initiation of several prospective randomized trials, including a large multicenter National Institutes of Health-sponsored effort ("RECESS"). 42 Our results show that fresh RBCs and those stored for Ն21 days produced statistically equivalent subtle deficits in pulmonary gas exchange for oxygen. While proving our hypothesis that acute lung dysfunction after transfusion can have a subtle as well as severe component, we also simultaneously demonstrated that transfusion of stored RBCs did not produce more impairment than did transfusion of fresh RBCs in the volunteers that we studied. If cytokines are involved, this finding may suggest that the in vivo cytokine response could be of greater importance than the cytokine concentrations in the supernatant fluid of stored RBCs. 
Red Cell Transfusion Induces Gas Exchange Deficit in Humans
The lack of differences of Pao 2 after transfusion would make clinical detection of such a subtle dysfunction difficult, because AaDo 2 is not calculated frequently. The changes in gas exchange of oxygen that we observed after transfusion of 2 U of RBCs are sufficiently small that they would be difficult to observe in a clinical setting. This may help explain why a minor form of the disorder may not have been clinically recognized previously. Additionally, it is possible that transfusion of a larger volume of RBCs might produce a greater impairment of gas exchange that would be sufficient for clinical detection. Even if AaDo 2 were to be calculated in patients, the absolute values of AaDo 2 that we observed after transfusion, although representing statistically significant increases, were small and were within the normal range. 43 Unless others examine changes in AaDo 2 (as did we), rather than absolute values, the absolute values of AaDo 2 would not be regarded as abnormal. Furthermore, AaDo 2 is least in the supine position because of the lesser distance from the bottom to the top of the lung, and thus there is lesser variation of V /Q . 19, 23 Because most patients would likely be supine if AaDo 2 were to be assessed, detection of an AaDo 2 abnormality would be even less likely. Additionally, patients breathing supplemental oxygen, but without their tracheas intubated, would have an inconstant Fio 2 , making accurate estimation of AaDo 2 impossible. Lastly, our study design maximized the ability to detect changes by using repeatedmeasures analysis; this design and robust analysis would not be possible in a clinical setting. However, it is possible that these changes after transfusion might be more substantial after transfusions of larger volume.
The modest increases seen in IL-6, IL-8, and VEGF in the recipients of stored LR and non-LR RBC units may reflect a mild proinflammatory effect of these units, because these cytokines are mainly associated with acute inflammatory reactions. 44 VEGF has a direct effect on vascular permeability through its ability to induce changes in endothelial cell adhesion and tight junction formation. 32, 45 VEGF increases pulmonary vascular permeability 33 and overexpression of VEGF in mice produces pulmonary edema. 34, 35 Mild changes in vascular permeability would likely underlie the differences seen in AaDo 2 in some of the transfusion recipients.
We found that Vd/Vt did not change with transfusion of either fresh or stored RBCs. Although increased Vd/Vt is a feature of early acute respiratory distress syndrome 18 and is associated with increased mortality in those with acute respiratory distress syndrome, Vd/Vt is more sensitive to changes in pulmonary perfusion than ventilation. 46 Vd/Vt is less in the supine than in the standing position owing to nonperfused, ventilated alveoli at upper lung regions when the lungs are longitudinal. Thus, it is not surprising that the changes in AaDo 2 were not accompanied by changes in Vd/Vt, and implies that the changes we observed were not related to pulmonary perfusion. 46 
Critique
Several issues of our study deserve discussion. We did not find a difference between fresh and stored RBCs for the small, but statistically significant decrements in the primary outcome variable, pulmonary gas exchange for oxygen as assessed by AaDo 2 or for Pao 2 . AaDo 2 is a more reliable measure, because it is true gas exchange and accounts for other variables (R and Paco 2 ) that influence Pao 2 . Our study was powered to detect changes in AaDo 2 , but not Pao 2 . Similarly, it should be noted that our study design did not allow for repeated-measures analysis for comparison of LR and non-LR RBC transfusion and was not powered for this variable, and thus that comparison was less robust to permit detection of any difference(s) should it exist.
There is another possible interpretation of the etiology of our finding for changes in AaDo 2 . Inasmuch as the changes produced by fresh or stored RBCs did not differ, it is possible that they resulted from the augmentation of blood volume per se. The infusion of Ͻ300 mL RBCs (representing approximately Ͻ7% of the volunteers' blood volume) would have initially augmented blood volume by not more than this amount, but with time fluid shifts would have partially ameliorated toward normal both that increase and extracellular volume changes. Furthermore, all volunteers were healthy and relatively young, with compliant vessels and myocardium; the small augmentation would not likely have altered cardiac preload or afterload. We could have controlled partially for this variable by studying each volunteer a third time without withdrawing 2 U of blood, but with administration of an equivalent volume of colloid. However, pharmacokinetic differences between these colloids and RBCs would not provide an exactly equivalent control. Our assertion that the relatively small volume per se of RBCs transfused did not cause the changes we noted in gas exchange is supported by the stability of the volunteers' arterial blood pressure (4 mm Hg non-statistically significant difference) and was in keeping with blood pressure changes in similar volunteers undergoing isovolemic hemodilution, owing to changes in hemoglobin concentration and systemic vascular resistance 20 (viscosity and total vessel cross-sectional area 47 ). Our calculations for AaDo 2 included an assumption for the value of R, because we did not measure oxygen consumption. Regional lung R varies with body position and within the lung based on regional differences in V a/Q . 19, 23 Use of 0.86 is a reasonable estimate based on the body position of our volunteers, because in the supine position, any regional V /Q variations are small and the semirecumbent position serves to lessen the differences of the erect position, and published values. 22, 23 Any difference between the value used and the true overall average value would have been small and have had a minor effect on calculated Pao 2 and thus AaDo 2 . Furthermore, any difference would have been included in all calculations for AaDo 2 and thus would not likely have affected the value of the primary outcome measure, the change in AaDo 2 .
The purpose of our study was to test whether stored RBCs could alter pulmonary function. We did not focus on mechanisms of a potential effect, because we did not know a priori whether there would be any changes with RBC transfusion. Assessments of cytokine concentrations and neutrophil priming could be a logical next step to further identify the mechanisms responsible for the changes we observed. Thus, our exploratory evaluations of potential mechanisms were limited, and further constrained by the covariation of most cytokines. The observed correlation of in vivo VEGF concentrations and AaDo 2 , and the knowledge of the action of VEGF on endothelial layers and pulmonary vascular permeability, are suggestive that VEGF may have a role in the small oxygenation changes we detected, but do not provide proof.
Although the magnitude of the observed changes was small, it is possible that these would be amplified with higher volume transfusions or in patients with underlying disease or with an inflammatory state with either primed neutrophils or increased pulmonary vascular permeability. This study is the first demonstration of decrement in gas exchange of oxygen after autologous RBC transfusion, and points to factors other than antibody-antigen reactions as an etiology.
We conclude that RBC transfusion causes subtle pulmonary dysfunction, as evidenced by impaired gas exchange for oxygen, supporting our hypothesis that lung impairment after transfusion includes a wide spectrum of physiologic derangements and may not require an existing state of altered physiology. These data do not support the hypothesis that transfusion of RBCs stored for Ͼ21 days is more injurious than that of fresh RBCs in healthy people. These findings may not apply to those at higher risk for pulmonary injury because of an underlying condition or disease. Similarly, we did not concomitantly transfuse plasma or platelets, and it is possible that these might accentuate the observed RBC-induced impairment. The data suggest that VEGF may have a role in the small oxygenation changes that we detected.
